PURPLZ 100MG VIAL INJECTION contains Bendamustine, which belongs to the class of alkylating agents. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. This medicine is used in the treatment of chronic lymphocytic leukemia and non-Hodgkin’s leukemia.

FAQs

How does PURPLZ 100MG VIAL INJECTION work?

PURPLZ 100MG VIAL INJECTION contains Bendamustine, which inhibits the DNA and RNA transcription essential for cancer cell growth.

What are the conditions to be noted while receiving PURPLZ 100MG VIAL INJECTION?

PURPLZ 100MG VIAL INJECTION may cause reactivation of serious infections, myelosuppression, tumour lysis syndrome, and anaphylactic reactions in some patients. Hence, inform your oncologist about your complete medical history, including current medication, to rule out any side effects/interactions.